| 摘要 |
<p>Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for treating conditions such as, for example, Parkinson's disease, Alzheimer's disease, migraine, epilepsy and pain.</p> |
| 申请人 |
MERCK & CO., INC.;LIVERTON, NIGEL, J.;CLAIBORNE, CHRISTOPHER, F.;CLAREMON, DAVID, A.;MCCAULEY, JOHN, A. |
发明人 |
LIVERTON, NIGEL, J.;CLAIBORNE, CHRISTOPHER, F.;CLAREMON, DAVID, A.;MCCAULEY, JOHN, A. |
